EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Huangkui capsules for diabetic nephropathy: Comprehensive review of efficacy and molecular mechanisms

Xueyin Chen, Yan Yu, Cuixia Xiao, Shaowei Li, Tongtong Wu, Han Wu, Xinying Li, Chenglin Lin, Xiaoli Chen, Xinfeng Guo, Shaonan Liu

Phytomedicine · 2025-11 · 147 · 157207

DOI: 10.1016/j.phymed.2025.157207 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Phytomedicine, 2025-11. Verfasst von Xueyin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Reseach, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Med…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Drugs, Chinese Herbal, Phytotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The management of kidney diseases urgently needs additional therapeutic options. Encouraging evidence suggests the efficacy of Huangkui capsules (HKCs), a plant-derived traditional medicine, in treating various subtypes of nephropathy. However, current evidence is fragmented between clinical outcomes and mechanistic insights. PURPOSE: This study synthesized randomized controlled trials (RCTs), meta-analysis, and preclinical data to explore the effectiveness and mechanisms of action of HKCs. STUDY DESIGN: Evidence map and meta-analysis. METHODS: Seven databases were searched for RCTs and meta-analysis on the use of HKCs for nephropathies, as well as animal studies examining the effects of HKCs on diabetic nephropathy (DN). Data on baseline information, renal function indicators, glycemic control, lipid profiles, and inflammatory markers were extracted. Evidence was synthesized using a meta-analytical approach. RESULTS: Our evidence map highlighted the effect of HKCs on DN, particularly on urinary protein excretion as a key outcome measure. In the meta-analysis of clinical studies, HKCs demonstrated significant improvements in renal function indicators, inflammatory markers, and lipid profiles. In the meta-analysis of animal studies, HKCs demonstrated significant beneficial effects on renal function in DN models. Specifically, substantial reductions in 24-hour urine protein values were observed in the high-dose group (100-200 mg/kg). Mechanistic reviews indicated that HKCs exert a multi-target, comprehensive regulatory effect on DN. CONCLUSIONS: This study provides compelling and robust evidence supporting the clinical translation of HKCs and highlights their value as a therapeutic option for nephropathies, particularly in the context of DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesDrugs, Chinese HerbalPhytotherapyAnimalsHumansCapsulesRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Diabetic nephropathyEvidence mapHuangkui capsulesMeta-analysisNephropathies

Substanzen

Drugs, Chinese HerbalCapsulesHuangkui

Autor:innen und Institutionen

  • Center for Clinical Reseach, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
  • Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • Center for Clinical Reseach, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: guoxinfeng@gzucm.e…
  • Center for Clinical Reseach, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. Electronic address: shaonanliu819@gzuc…

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Chen, X., Yu, Y., Xiao, C., Li, S., Wu, T., Wu, H., Li, X., Lin, C., Chen, X., Guo, X., & Liu, S. (2025). Huangkui capsules for diabetic nephropathy: Comprehensive review of efficacy and molecular mechanisms. Phytomedicine, 147, 157207. https://doi.org/10.1016/j.phymed.2025.157207

Vancouver

Chen X, Yu Y, Xiao C, Li S, Wu T, Wu H, et al. Huangkui capsules for diabetic nephropathy: Comprehensive review of efficacy and molecular mechanisms. Phytomedicine. 2025;147:157207. doi:10.1016/j.phymed.2025.157207

BibTeX
@article{Chen2025,
  author = {Chen, Xueyin and Yu, Yan and Xiao, Cuixia and Li, Shaowei and Wu, Tongtong and Wu, Han and Li, Xinying and Lin, Chenglin and Chen, Xiaoli and Guo, Xinfeng and Liu, Shaonan},
  title = {Huangkui capsules for diabetic nephropathy: Comprehensive review of efficacy and molecular mechanisms},
  journal = {Phytomedicine},
  year = {2025},
  volume = {147},
  pages = {157207},
  doi = {10.1016/j.phymed.2025.157207}
}
Kostenlos starten →